cancer_drugs_approved.jpeg
This photo provided by Genentech, a member of the Roche Group, shows the drug Tecentriq. U.S. regulators have approved Tecentriq, the first drug for bladder cancer that harnesses the body's immune system. It is the first advance in decades against the most common type of bladder cancer, one which almost always kills patients within months. (Genentech via AP) MANDATORY CREDIT
Featured Photo Galleries
Military parade celebrates Army’s 250th
Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.
Ovi scores goal 890, Caps lose to Sabres 8-5
Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)
Hegseth joins veterans, generals to mark 80th anniversary of battle of Iwo Jima
A handful of retired Marines – all in the late 90s or over 100 — joined Defense Secretary Pete Hegseth and Japan’s Prime Minister Takeru Ishida on Saturday to mark the anniversary of one of the bloodiest battles of World War II in the Pacific that ended 80 years ago this week.
